AU782005B2 — Immediate release medicinal compositions for oral use
Assigned to Kissei Pharmaceutical Co Ltd · Expires 2005-06-30 · 21y expired
What this patent protects
The present invention relates to an immediate release oral pharmaceutical composition which comprises as an active ingredient the calcium salt of a benzylsuccinic acid derivative represented by the formula: <CHEM> or its hydrate, which is useful as an agent for the treatmen…
USPTO Abstract
The present invention relates to an immediate release oral pharmaceutical composition which comprises as an active ingredient the calcium salt of a benzylsuccinic acid derivative represented by the formula: <CHEM> or its hydrate, which is useful as an agent for the treatment of diabetes.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.